Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission

RATIONALE: Schizophrenia remains among the most prevalent neuropsychiatric disorders, and current treatment options are accompanied by unwanted side effects. New treatments that better address core features of the disease with minimal side effects are needed. OBJECTIVES: As a new therapeutic approac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Psychopharmacology (Berl)
Main Authors: Snyder, Gretchen L., Vanover, Kimberly E., Zhu, Hongwen, Miller, Diane B., O’Callaghan, James P., Tomesch, John, Li, Peng, Zhang, Qiang, Krishnan, Vaishnav, Hendrick, Joseph P., Nestler, Eric J., Davis, Robert E., Wennogle, Lawrence P., Mates, Sharon
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2014
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4302236/
https://ncbi.nlm.nih.gov/pubmed/25120104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-014-3704-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados